FENNEC PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
FENNEC PHARMACEUTICALS INC. (FENC) had Shares Outstanding (Cover Page) of 35.07 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 35.07M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 34.74M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 34.48M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 28.12M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 35.07M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 34.74M shares 10-Q · filed 2026-05-14 |
| 2026-03-20 | 34.48M shares 10-K · filed 2026-03-27 |
| 2025-11-10 | 28.12M shares 10-Q · filed 2025-11-13 |
| 2025-08-11 | 27.83M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 27.62M shares 10-Q · filed 2025-05-14 |
| 2025-03-24 | 27.59M shares 10-K · filed 2025-03-26 |
| 2024-11-05 | 27.43M shares 10-Q · filed 2024-11-08 |
| 2024-08-08 | 27.36M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 27.32M shares 10-Q · filed 2024-05-14 |
| 2024-03-25 | 27.10M shares 10-K · filed 2024-03-29 |
| 2023-11-03 | 26.63M shares 10-Q · filed 2023-11-09 |
| 2023-08-02 | 26.57M shares 10-Q · filed 2023-08-07 |
| 2023-05-09 | 26.42M shares 10-Q · filed 2023-05-12 |
| 2023-03-27 | 26.41M shares 10-K · filed 2023-03-29 |
| 2022-11-11 | 26.24M shares 10-Q · filed 2022-11-14 |
| 2022-08-11 | 26.07M shares 10-Q · filed 2022-08-12 |
| 2022-05-09 | 26.04M shares 10-Q · filed 2022-05-12 |
| 2022-02-25 | 26.01M shares 10-K · filed 2022-02-28 |
| 2021-11-09 | 26.01M shares 10-Q · filed 2021-11-10 |
| 2021-08-09 | 26.01M shares 10-Q · filed 2021-08-10 |
| 2021-05-11 | 26.00M shares 10-Q · filed 2021-05-13 |
| 2021-03-29 | 26.00M shares 10-K · filed 2021-03-30 |
| 2020-11-11 | 25.81M shares 10-Q · filed 2020-11-16 |
| 2020-08-04 | 25.36M shares 10-Q · filed 2020-08-05 |
| 2020-05-13 | 25.36M shares 10-Q · filed 2020-05-14 |
| 2020-02-11 | 19.90M shares 10-K · filed 2020-02-14 |
| 2019-11-12 | 19.90M shares 10-Q · filed 2019-11-12 |
| 2019-08-09 | 19.90M shares 10-Q · filed 2019-08-09 |
| 2019-05-10 | 19.90M shares 10-Q · filed 2019-05-10 |
| 2019-03-11 | 19.90M shares 10-K · filed 2019-03-15 |
| 2018-11-13 | 19.73M shares 10-Q · filed 2018-11-13 |
| 2018-08-13 | 18.93M shares 10-Q · filed 2018-08-13 |
| 2018-05-14 | 18.50M shares 10-Q · filed 2018-05-14 |
| 2018-03-16 | 18.46M shares 10-K · filed 2018-03-28 |
| 2017-11-13 | 15.87M shares 10-Q · filed 2017-11-13 |
| 2017-08-14 | 15.63B shares 10-Q · filed 2017-08-14 |
| 2017-05-12 | 13.71M shares 10-Q · filed 2017-05-12 |
| 2017-03-17 | 13.64M shares 10-K · filed 2017-03-29 |
| 2016-11-11 | 13.64M shares 10-Q · filed 2016-11-14 |
| 2016-08-12 | 13.64M shares 10-Q · filed 2016-08-12 |
| 2016-05-12 | 12.10M shares 10-Q · filed 2016-05-12 |
| 2016-03-18 | 10.94M shares 10-K · filed 2016-03-28 |
| 2015-11-12 | 10.94M shares 10-Q · filed 2015-11-12 |
| 2015-08-11 | 10.92M shares 10-Q · filed 2015-08-11 |
| 2015-05-14 | 10.62M shares 10-Q · filed 2015-05-15 |
| 2015-03-16 | 10.62M shares 10-K · filed 2015-03-31 |
| 2014-11-13 | 9.86M shares 10-Q · filed 2014-11-13 |
| 2014-08-08 | 29.58M shares 10-Q · filed 2014-08-11 |
| 2014-05-14 | 29.31M shares 10-Q · filed 2014-05-15 |
| 2014-03-14 | 29.31M shares 10-K · filed 2014-03-31 |
| 2013-11-10 | 25.16M shares 10-Q · filed 2013-11-18 |
| 2013-08-10 | 25.16M shares 10-Q · filed 2013-08-09 |
| 2013-05-13 | 25.16M shares 10-Q · filed 2013-05-13 |
| 2013-03-16 | 25.16M shares 10-K · filed 2013-04-01 |
| 2012-11-10 | 25.16M shares 10-Q · filed 2012-11-14 |
| 2012-08-10 | 25.16M shares 10-Q · filed 2012-08-13 |
| 2012-05-10 | 25.16M shares 10-Q · filed 2012-05-15 |
| 2012-03-16 | 25.16M shares 10-K · filed 2012-03-27 |
| 2011-11-12 | 25.16M shares 10-Q · filed 2011-11-14 |
| 2011-08-12 | 452.85M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |